<p>Oscar Health, Inc.（纽约证券交易所代码：OSCR - 获取免费报告）在周四的午盘交易中下跌了 7.9%，原因是巴克莱将该股票的目标价从 17.00 美元下调至 11.00 美元。巴克莱目前对该股票的评级为减持。Oscar Health 的股价最低曾达到 14.65 美元，最后交易价为 14.62 美元。在交易过程中，约有 20,708,746 股成交，较平均每日成交量 12,433,063 股增加了 67%。该股票此前收盘价为 15.87 美元。</p>
<ul>
<li>5 只具有爆炸性上涨潜力的小型股</li>
</ul>
<p>其他一些研究分析师也最近对 OSCR 发表了评论。富国银行将 Oscar Health 的评级从 “持平” 下调至 “减持”，并在 7 月 11 日的研究报告中将该公司的目标价从 16.00 美元下调至 10.00 美元。派珀·桑德勒将 Oscar Health 的评级从 “增持” 下调至 “中性”，并在 7 月 14 日的研究报告中设定了 14.00 美元的目标价。华尔街 Zen 在 6 月 8 日的研究报告中将 Oscar Health 的评级从 “买入” 下调至 “持有”。瑞银集团在 7 月 15 日的研究报告中重申了 “卖出” 评级，并将 Oscar Health 的目标价下调至 11.00 美元（之前为 15.00 美元）。最后，雷蒙德·詹姆斯金融在 6 月 24 日的研究报告中将 Oscar Health 的评级从 “跑赢大盘” 下调至 “市场表现”。五位研究分析师对该股票给予了 “卖出” 评级，三位分析师给予了 “持有” 评级。根据 MarketBeat 的数据，Oscar Health 目前的共识评级为 “减持”，平均目标价为 11.92 美元。</p>
<p><strong>阅读我们关于 Oscar Health 的最新股票报告</strong></p>
<h2>内部买卖</h2>
<p>在相关消息中，董事 Elbert O. Jr. Robinson 在 5 月 12 日的交易中出售了 25,000 股公司的股票。该股票以平均价格 16.43 美元出售，总价值为 410,750.00 美元。出售后，该董事直接持有公司 64,512 股股票，价值为 1,059,932.16 美元。这代表其持股比例减少了 27.93%。该出售在与 SEC 的法律文件中披露，文件可通过此链接获取。24.39% 的股票由内部人士持有。</p>
<h2>对 Oscar Health 的对冲基金看法</h2>
<p>一些机构投资者和对冲基金最近修改了对该公司的持股。汇丰控股在第一季度将其在 Oscar Health 的持股比例提高了 2.7%。汇丰控股目前拥有 24,113 股公司股票，价值为 313,000 美元，此前在该期间购买了 632 股。Tempus Wealth Planning LLC 在第一季度将其在 Oscar Health 的持股比例提高了 6.7%。Tempus Wealth Planning LLC 目前拥有 14,392 股公司股票，价值为 189,000 美元，此前在上个季度购买了 906 股。Focus Partners Wealth 在第一季度将其在 Oscar Health 的持股比例提高了 1.8%。Focus Partners Wealth 目前拥有 55,158 股公司股票，价值为 723,000 美元，此前在上个季度购买了 949 股。Xponance Inc.在第一季度将其在 Oscar Health 的持股比例提高了 7.1%。Xponance Inc.目前拥有 15,423 股公司股票，价值为 202,000 美元，此前在上个季度购买了 1,029 股。最后，CWM LLC 在第一季度将其在 Oscar Health 的持股比例提高了 50.7%。CWM LLC 目前拥有 3,204 股公司股票，价值为 42,000 美元，此前在上个季度购买了 1,078 股。当前 75.70% 的股票由机构投资者持有。</p>
<h2>Oscar Health 的价格表现</h2>
<p>该公司的市值为 37.3 亿美元，市盈率为 52.20，贝塔值为 1.90。该公司的 50 日移动平均线为 16.10 美元，200 日移动平均线为 14.92 美元。公司的流动比率为 0.88，速动比率为 0.88，债务与股本比率为 0.22。</p>
<p>Oscar Health（纽约证券交易所代码：OSCR - 获取免费报告）最后一次公布财报是在 5 月 7 日，报告显示该公司季度每股收益（EPS）为 0.92 美元，超出市场共识预期的 0.83 美元，超出幅度为 0.09 美元。Oscar Health 的股本回报率为 10.59%，净利润率为 1.22%。该公司在该季度的收入为 30 亿美元，而分析师预期为 28.7 亿美元。去年同期，该公司每股收益为 0.62 美元。与去年同期相比，该公司的收入增长了 42.2%。整体来看，研究分析师预计 Oscar Health, Inc.在当前财政年度将发布 0.69 美元的每股收益。</p>
<h2>关于 Oscar Health</h2>
<p>（获取免费报告）</p>
<p>Oscar Health, Inc.在美国运营作为一家健康保险公司。该公司在个人和小型团体市场提供健康计划，以及 +Oscar，一个技术驱动的平台，帮助提供者和支付方直接实现向基于价值的护理转型。它还提供再保险产品。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们更看好的股票超过 Oscar Health</li>
<li>3 只股票引领了迷因股的复苏</li>
<li>为什么期权交易者对 Oracle 股票押注很大</li>
<li>消费者可选消费股票解析</li>
<li>Alphabet 的突破性季度预示着新的领导阶段</li>
<li>ETF 是否支付股息？你需要知道的事项</li>
<li>Rivian 股票在机器人出租车热潮中上涨</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Oscar Health 吗？</h2>
<p>在考虑 Oscar Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街评级最高和表现最佳的研究分析师及他们推荐给客户的股票。MarketBeat 已经识别出五只股票，顶级分析师正在悄悄地向他们的客户推荐现在购买，以便在更广泛的市场注意到之前……而 Oscar Health 并不在名单上。</p>
<p>虽然 Oscar Health 目前在分析师中被评为强烈卖出，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

OSCR

<p>奥斯卡健康（NYSE:OSCR）股价下跌 7.9%，因巴克莱将其目标价从 17.00 美元下调至 11.00 美元，并维持了减持评级。该股最低交易价为 14.65 美元，交易量显著增加。包括富国银行和派珀·桑德勒在内的其他分析师也下调了该股评级，导致市场共识评级为 “减持”，平均目标价为 11.92 美元。内部交易活动显示一名董事出售了 25,000 股，持股比例减少了 27.93%。奥斯卡健康在最新的财报中报告了 42.2% 的年同比收入增长</p>

<p>Oscar Health, Inc. (NYSE:OSCR - Get Free Report) dropped 7.9% during mid-day trading on Thursday after Barclays lowered their price target on the stock from $17.00 to $11.00. Barclays currently has an underweight rating on the stock. Oscar Health traded as low as $14.65 and last traded at $14.62. Approximately 20,708,746 shares changed hands during trading, an increase of 67% from the average daily volume of 12,433,063 shares. The stock had previously closed at $15.87.</p>
<div class="lb-trans"><p>Oscar Health, Inc.（纽约证券交易所代码：OSCR - 获取免费报告）在周四的午盘交易中下跌了 7.9%，原因是巴克莱将该股票的目标价从 17.00 美元下调至 11.00 美元。巴克莱目前对该股票的评级为减持。Oscar Health 的股价最低曾达到 14.65 美元，最后交易价为 14.62 美元。在交易过程中，约有 20,708,746 股成交，较平均每日成交量 12,433,063 股增加了 67%。该股票此前收盘价为 15.87 美元。</p>
</div><ul>
<li>5 Small Cap Stocks With Explosive Upside Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只具有爆炸性上涨潜力的小型股</li>
</ul>
</div><p>A number of other research analysts also recently commented on OSCR. Wells Fargo &amp; Company downgraded Oscar Health from an &#34;equal weight&#34; rating to an &#34;underweight&#34; rating and dropped their price target for the company from $16.00 to $10.00 in a research note on Friday, July 11th. Piper Sandler downgraded Oscar Health from an &#34;overweight&#34; rating to a &#34;neutral&#34; rating and set a $14.00 price target for the company. in a research note on Monday, July 14th. Wall Street Zen downgraded Oscar Health from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research note on Sunday, June 8th. UBS Group restated a &#34;sell&#34; rating and issued a $11.00 target price (down previously from $15.00) on shares of Oscar Health in a research report on Tuesday, July 15th. Finally, Raymond James Financial lowered shares of Oscar Health from an &#34;outperform&#34; rating to a &#34;market perform&#34; rating in a research report on Tuesday, June 24th. Five research analysts have rated the stock with a sell rating and three have issued a hold rating to the company's stock. Based on data from MarketBeat, Oscar Health presently has a consensus rating of &#34;Reduce&#34; and an average price target of $11.92.</p>
<div class="lb-trans"><p>其他一些研究分析师也最近对 OSCR 发表了评论。富国银行将 Oscar Health 的评级从 “持平” 下调至 “减持”，并在 7 月 11 日的研究报告中将该公司的目标价从 16.00 美元下调至 10.00 美元。派珀·桑德勒将 Oscar Health 的评级从 “增持” 下调至 “中性”，并在 7 月 14 日的研究报告中设定了 14.00 美元的目标价。华尔街 Zen 在 6 月 8 日的研究报告中将 Oscar Health 的评级从 “买入” 下调至 “持有”。瑞银集团在 7 月 15 日的研究报告中重申了 “卖出” 评级，并将 Oscar Health 的目标价下调至 11.00 美元（之前为 15.00 美元）。最后，雷蒙德·詹姆斯金融在 6 月 24 日的研究报告中将 Oscar Health 的评级从 “跑赢大盘” 下调至 “市场表现”。五位研究分析师对该股票给予了 “卖出” 评级，三位分析师给予了 “持有” 评级。根据 MarketBeat 的数据，Oscar Health 目前的共识评级为 “减持”，平均目标价为 11.92 美元。</p>
</div><p><strong>Read Our Latest Stock Report on Oscar Health</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 Oscar Health 的最新股票报告</strong></p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部买卖</h2>
</div><p>In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the company's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $16.43, for a total value of $410,750.00. Following the sale, the director directly owned 64,512 shares in the company, valued at $1,059,932.16. This represents a 27.93% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 24.39% of the stock is owned by insiders.</p>
<div class="lb-trans"><p>在相关消息中，董事 Elbert O. Jr. Robinson 在 5 月 12 日的交易中出售了 25,000 股公司的股票。该股票以平均价格 16.43 美元出售，总价值为 410,750.00 美元。出售后，该董事直接持有公司 64,512 股股票，价值为 1,059,932.16 美元。这代表其持股比例减少了 27.93%。该出售在与 SEC 的法律文件中披露，文件可通过此链接获取。24.39% 的股票由内部人士持有。</p>
</div><h2>Hedge Funds Weigh In On Oscar Health</h2>
<div class="lb-trans"><h2>对 Oscar Health 的对冲基金看法</h2>
</div><p>A number of institutional investors and hedge funds have recently modified their holdings of the business. Hsbc Holdings PLC raised its position in shares of Oscar Health by 2.7% during the first quarter. Hsbc Holdings PLC now owns 24,113 shares of the company's stock worth $313,000 after purchasing an additional 632 shares during the period. Tempus Wealth Planning LLC raised its position in Oscar Health by 6.7% in the 1st quarter. Tempus Wealth Planning LLC now owns 14,392 shares of the company's stock valued at $189,000 after buying an additional 906 shares during the last quarter. Focus Partners Wealth raised its position in Oscar Health by 1.8% in the 1st quarter. Focus Partners Wealth now owns 55,158 shares of the company's stock valued at $723,000 after buying an additional 949 shares during the last quarter. Xponance Inc. raised its position in Oscar Health by 7.1% in the 1st quarter. Xponance Inc. now owns 15,423 shares of the company's stock valued at $202,000 after buying an additional 1,029 shares during the last quarter. Finally, CWM LLC raised its position in Oscar Health by 50.7% in the 1st quarter. CWM LLC now owns 3,204 shares of the company's stock valued at $42,000 after buying an additional 1,078 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>一些机构投资者和对冲基金最近修改了对该公司的持股。汇丰控股在第一季度将其在 Oscar Health 的持股比例提高了 2.7%。汇丰控股目前拥有 24,113 股公司股票，价值为 313,000 美元，此前在该期间购买了 632 股。Tempus Wealth Planning LLC 在第一季度将其在 Oscar Health 的持股比例提高了 6.7%。Tempus Wealth Planning LLC 目前拥有 14,392 股公司股票，价值为 189,000 美元，此前在上个季度购买了 906 股。Focus Partners Wealth 在第一季度将其在 Oscar Health 的持股比例提高了 1.8%。Focus Partners Wealth 目前拥有 55,158 股公司股票，价值为 723,000 美元，此前在上个季度购买了 949 股。Xponance Inc.在第一季度将其在 Oscar Health 的持股比例提高了 7.1%。Xponance Inc.目前拥有 15,423 股公司股票，价值为 202,000 美元，此前在上个季度购买了 1,029 股。最后，CWM LLC 在第一季度将其在 Oscar Health 的持股比例提高了 50.7%。CWM LLC 目前拥有 3,204 股公司股票，价值为 42,000 美元，此前在上个季度购买了 1,078 股。当前 75.70% 的股票由机构投资者持有。</p>
</div><h2>Oscar Health Price Performance</h2>
<div class="lb-trans"><h2>Oscar Health 的价格表现</h2>
</div><p>The firm has a market capitalization of $3.73 billion, a PE ratio of 52.20 and a beta of 1.90. The business has a 50-day moving average of $16.10 and a 200 day moving average of $14.92. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.22.</p>
<div class="lb-trans"><p>该公司的市值为 37.3 亿美元，市盈率为 52.20，贝塔值为 1.90。该公司的 50 日移动平均线为 16.10 美元，200 日移动平均线为 14.92 美元。公司的流动比率为 0.88，速动比率为 0.88，债务与股本比率为 0.22。</p>
</div><p>Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.83 by $0.09. Oscar Health had a return on equity of 10.59% and a net margin of 1.22%. The firm had revenue of $3 billion during the quarter, compared to analyst estimates of $2.87 billion. During the same period last year, the firm posted $0.62 EPS. The business's revenue was up 42.2% compared to the same quarter last year. As a group, research analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Oscar Health（纽约证券交易所代码：OSCR - 获取免费报告）最后一次公布财报是在 5 月 7 日，报告显示该公司季度每股收益（EPS）为 0.92 美元，超出市场共识预期的 0.83 美元，超出幅度为 0.09 美元。Oscar Health 的股本回报率为 10.59%，净利润率为 1.22%。该公司在该季度的收入为 30 亿美元，而分析师预期为 28.7 亿美元。去年同期，该公司每股收益为 0.62 美元。与去年同期相比，该公司的收入增长了 42.2%。整体来看，研究分析师预计 Oscar Health, Inc.在当前财政年度将发布 0.69 美元的每股收益。</p>
</div><h2>About Oscar Health</h2>
<div class="lb-trans"><h2>关于 Oscar Health</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.</p>
<div class="lb-trans"><p>Oscar Health, Inc.在美国运营作为一家健康保险公司。该公司在个人和小型团体市场提供健康计划，以及 +Oscar，一个技术驱动的平台，帮助提供者和支付方直接实现向基于价值的护理转型。它还提供再保险产品。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Oscar Health</li>
<li>3 Tickers Leading a Meme Stock Revival</li>
<li>Why Options Traders Are Betting Big on Oracle Stock</li>
<li>Consumer Discretionary Stocks Explained</li>
<li>Alphabet’s Breakout Quarter Signals a New Leadership Phase</li>
<li>Do ETFs Pay Dividends? What You Need to Know</li>
<li>Rivian Stock Rallies as Robotaxi Buzz Builds</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过 Oscar Health</li>
<li>3 只股票引领了迷因股的复苏</li>
<li>为什么期权交易者对 Oracle 股票押注很大</li>
<li>消费者可选消费股票解析</li>
<li>Alphabet 的突破性季度预示着新的领导阶段</li>
<li>ETF 是否支付股息？你需要知道的事项</li>
<li>Rivian 股票在机器人出租车热潮中上涨</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Oscar Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Oscar Health 吗？</h2>
</div><p>Before you consider Oscar Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Oscar Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街评级最高和表现最佳的研究分析师及他们推荐给客户的股票。MarketBeat 已经识别出五只股票，顶级分析师正在悄悄地向他们的客户推荐现在购买，以便在更广泛的市场注意到之前……而 Oscar Health 并不在名单上。</p>
</div><p>While Oscar Health currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Oscar Health 目前在分析师中被评为强烈卖出，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Oscar Health (NYSE:OSCR) 的股价在分析师下调评级后下跌了 7.9%